Prognostic impact of biomarkers in PMBCL: rationale for early integration of immune checkpoint inhibitors
{{output}}
Aim: This research aims to guide future strategies for personalized treatment of primary mediastinal large B-cell lymphoma (PMBCL), particularly to identify high-risk patients who may benefit from incorporating immune checkpoint ... ...
